Hematological cancer: Localized non-bulky Hodgkin lymphoma--future questions

Nat Rev Clin Oncol. 2012 Jan 31;9(3):129-30. doi: 10.1038/nrclinonc.2012.7.
No abstract available

Publication types

  • News

MeSH terms

  • Antineoplastic Agents / therapeutic use
  • Bleomycin / therapeutic use
  • Dacarbazine / therapeutic use
  • Doxorubicin / therapeutic use
  • Hematologic Neoplasms / drug therapy
  • Hematologic Neoplasms / mortality
  • Hematologic Neoplasms / radiotherapy*
  • Hodgkin Disease / drug therapy
  • Hodgkin Disease / mortality
  • Hodgkin Disease / radiotherapy*
  • Humans
  • Radiotherapy / adverse effects*
  • Survival Analysis
  • Treatment Outcome
  • United States
  • Vinblastine / therapeutic use

Substances

  • Antineoplastic Agents
  • Bleomycin
  • Vinblastine
  • Dacarbazine
  • Doxorubicin